Guest speaker Dr Carrie Nelson discusses her experience using technology-enabled care models, emphasizing the importance of health equity and personalized approaches to patient care, particularly in the context of COVID-19.
Guest speaker Dr Carrie Nelson discusses her experience using technology-enabled care models, emphasizing the importance of health equity and personalized approaches to patient care, particularly in the context of COVID-19.
Rich Steinle, CEO of Carium, shares Carium's unique care experience platform and its award-winning methods of enhancing patient and provider user experiences.
Rich Steinle, CEO of Carium, shares Carium's unique care experience platform and its award-winning methods of enhancing patient and provider user experiences.
Mitchell A. Kaminski, MD, MBA, and David Nash, MD, MBA, continue their discussion of the challenges spotlighted by the COVID-19 pandemic and the way stakeholders can approach solutions in the future.
Mitchell A. Kaminski, MD, MBA, and David Nash, MD, MBA, continue their discussion of the challenges spotlighted by the COVID-19 pandemic and the way stakeholders can approach solutions in the future.
Victor Wang, SVP of Data & Research at Q-Centrix, shares new research findings about the collection and use of real-world data from hospitals and health systems to improve clinical trials.
Victor Wang, SVP of Data & Research at Q-Centrix, shares new research findings about the collection and use of real-world data from hospitals and health systems to improve clinical trials.
Mitchell A. Kaminski, MD, MBA, and David Nash, MD, MBA, both affiliated with Jefferson College of Population Health, sit down together to discuss the book How COVID Crashed the System.
Mitchell A. Kaminski, MD, MBA, and David Nash, MD, MBA, both affiliated with Jefferson College of Population Health, sit down together to discuss the book How COVID Crashed the System.
Cheryl Dalton-Norman, MBA, BSN, RN, president and cofounder, Conduit Health Partners, comments on how the combination of RSV, COVID-19, and flu impacted health systems, as well as how organizations can optimize their workflows to meet surges...
Cheryl Dalton-Norman, MBA, BSN, RN, president and cofounder, Conduit Health Partners, comments on how the combination of RSV, COVID-19, and flu impacted health systems, as well as how organizations can optimize their workflows to meet surges...
Colin Banas, MD, MHA, chief medical officer, DrFirst, reviews survey findings which suggest a significant portion of patients abandon prescriptions due to cost, and shares how price transparency tools can inform and improve prescribing...
Colin Banas, MD, MHA, chief medical officer, DrFirst, reviews survey findings which suggest a significant portion of patients abandon prescriptions due to cost, and shares how price transparency tools can inform and improve prescribing...
Mark Spinner, president and CEO, AccessOne, discusses how patients have taken on a larger share of health care costs in recent years, as well as how organizations can improve the consumer experience while optimizing their cost structures.
Mark Spinner, president and CEO, AccessOne, discusses how patients have taken on a larger share of health care costs in recent years, as well as how organizations can improve the consumer experience while optimizing their cost structures.
Morris Panner, president of Intelerad, discusses the impact of large hospital system consolidations, trends and perspectives around the future of medical imaging, and the latest advances in AI and analytics.
Morris Panner, president of Intelerad, discusses the impact of large hospital system consolidations, trends and perspectives around the future of medical imaging, and the latest advances in AI and analytics.
Frank McGillin, CEO, The Clinic by Cleveland Clinic, discusses the importance of reducing misdiagnoses to contain costs, as well as how the shift to virtual care brought on by the pandemic can ensure patient access to second opinions.
Frank McGillin, CEO, The Clinic by Cleveland Clinic, discusses the importance of reducing misdiagnoses to contain costs, as well as how the shift to virtual care brought on by the pandemic can ensure patient access to second opinions.
Roy Moore outlines how a rapidly expanding atopic dermatitis pipeline is intensifying competition, reshaping payer strategies, and raising the bar for new therapies.
Roy Moore outlines how a rapidly expanding atopic dermatitis pipeline is intensifying competition, reshaping payer strategies, and raising the bar for new therapies.
Roy Moore of Clarivate’s market access team discussed the evolving migraine treatment landscape, highlighting the maturation of the acute and prophylactic markets, the emergence of new therapies such as triptan-COX-2 combinations, gepants,...
Roy Moore of Clarivate’s market access team discussed the evolving migraine treatment landscape, highlighting the maturation of the acute and prophylactic markets, the emergence of new therapies such as triptan-COX-2 combinations, gepants,...
Roy Moore, a market access expert, discusses the evolving asthma drug pipeline, highlighting upcoming therapies—including Breztri, depemokimab, and masitinib—their potential to improve adherence and outcomes, payer considerations around cost...
Roy Moore, a market access expert, discusses the evolving asthma drug pipeline, highlighting upcoming therapies—including Breztri, depemokimab, and masitinib—their potential to improve adherence and outcomes, payer considerations around cost...
In this edition of Pipeline Projections, Roy Moore breaks down the rapidly evolving landscape of multiple sclerosis treatments—highlighting the shift from injectables to orals, the rise of monoclonal antibodies, and the promise of innovative...
In this edition of Pipeline Projections, Roy Moore breaks down the rapidly evolving landscape of multiple sclerosis treatments—highlighting the shift from injectables to orals, the rise of monoclonal antibodies, and the promise of innovative...
In this episode of Pipeline Projections, Roy Moore—Senior Healthcare Research & Data Analyst at Clarivate—discusses the expanding biosimilar pipeline for autoimmune diseases. He highlights recent FDA approvals, formulary and pricing...
In this episode of Pipeline Projections, Roy Moore—Senior Healthcare Research & Data Analyst at Clarivate—discusses the expanding biosimilar pipeline for autoimmune diseases. He highlights recent FDA approvals, formulary and pricing...
The US Department of Health and Human Services (HHS) has formally scrapped its 340B Rebate Model Pilot Program following a series of court rulings that blocked its implementation—signaling a significant pause in one of the most closely...
The US Department of Health and Human Services (HHS) has formally scrapped its 340B Rebate Model Pilot Program following a series of court rulings that blocked its implementation—signaling a significant pause in one of the most closely...
On February 3, 2026, President Donald Trump signed a broad government funding package that includes multi-year extensions for Medicare teleath and hospital-at-home programs, new oversight requirements for pharmacy benefit managers (PBMs), and...
On February 3, 2026, President Donald Trump signed a broad government funding package that includes multi-year extensions for Medicare teleath and hospital-at-home programs, new oversight requirements for pharmacy benefit managers (PBMs), and...
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...